Osteopore Limited (ASX:OSX)

Market Cap	3.94M +22.0%
Revenue (ttm)	3.06M +10.7%
Net Income	-3.72M
EPS	-0.02
Shares Out	562.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,285
Average Volume	2,011,319
Open	0.0070
Previous Close	0.0070
Day's Range	0.0070 - 0.0070
52-Week Range	0.0050 - 0.0290
Beta	-0.06
RSI	55.02
Earnings Date	May 29, 2026

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2025, Osteopore's revenue was 3.06 million, an increase of 10.65% compared to the previous year's 2.76 million. Losses were -3.72 million, 11.0% more than in 2024.